Page last updated: 2024-10-31

metyrapone and Galactorrhea

metyrapone has been researched along with Galactorrhea in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Galactorrhea: Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birkenhäger, JC1
Upton, GV1
Seldenrath, HJ1
Krieger, DT1
Tashjian, AH1

Other Studies

1 other study available for metyrapone and Galactorrhea

ArticleYear
Medullary thyroid carcinoma: ectopic production of peptides with ACTH-like, corticotrophin releasing factor-like and prolactin production-stimulating activities.
    Acta endocrinologica, 1976, Volume: 83, Issue:2

    Topics: Adrenocorticotropic Hormone; Antigens; Biological Assay; Calcitonin; Carcinoma; Corticotropin-Releas

1976